Tag: SII
Browse our exclusive articles!
SII asks government to reduce time gap for Covid-19 vaccine booster dose
Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose to...
SII’s Covovax vaccine recommended for Phase 3 trial as booster dose in adults
The Subject Expert Committee of India`s apex drugs authority Drugs Controller General of India (DCGI) has recommended permission for vaccine manufacturer Serum Institute...
SII seeks permission for Covovax vaccine phase-3 study of booster dose in adults
Serum Institute of India has sought permission from India's drug regulator to conduct a phase-3 study of its COVID-19 vaccine Covovax as a...
SII CEO Adar Poonawalla makes BIG announcement on COVID-19 vaccine for children
Source: Reuters |Updated: Dec 14, 2021, 02:34 PM ISTAs the fear regarding the spread of the Omicron variant is intensifying day by day,...
How effective is Covishield against Omicron? SII CEO Adar Poonawalla says this
The first case of the new COVID-19 variant Omicron was detected in South Africa, but now it has spread to about 12 countries....
